Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



Three anticoagulant studies may change current medical practice

New research reveals that the practice of using the anticoagulants aspirin and heparin with the hope of preventing clots in placental blood vessels is ineffective for preventing unexplained, recurrent miscarriages. Two other studies look at treatments for venous thromboembolism, a common and sometimes deadly clotting disorder.
read more

share

Bayer's Novel Anticoagulant Rivaroxaban Recommended For EU Approval - Venous Blood Clot Prevention After Elective Hip Or Knee Replacement Surgery

Health : Medical News Today (6 years ago)

The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of the anticoagulant rivaroxaban (Xarelto®), taken as one tablet, once-daily, for the prevention of venous blood clots (deep vein thrombosis... Read Post

Study Published in the New England Journal of Medicine Finds Intra-Arterial Treatment for Clot Removal Is More Effective at Treating Stroke Than Standard Medical Care

Health : Newswise Medical News (3 days ago)

Investigators found that using intra-arterial treatment to remove a stroke-causing blood clot in a large vessel supplying blood to the brain provides better outcomes than trying to dissolve the clot using a clot-busting drug (lytic)... Read Post

Three Anticoagulant Studies May Change Current Medical Practice

Health : Medical News Today (5 years ago)

Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally,... Read Post


Copyright © 2011 Regator, LLC